Drug use-results survey of ombitasvir/paritaprevir/ritonavir coformulated tablet in patients with genotype 1 chronic hepatitis C with or without compensated cirrhosis-Reference-Cited by-同舟云学术

Drug use-results survey of ombitasvir/paritaprevir/ritonavir coformulated tablet in patients with genotype 1 chronic hepatitis C with or without compensated cirrhosis

Published:2021-11-01 Issue:11 Volume:62 Page:690-702
ISSN:0451-4203
Container-title:Kanzo
language:en
Short-container-title:Acta hepatologica Japonica

Author:

Mochida Satoshi¹,Sakuma Ryuta²,Nakajima Ryo²,Kawaberi Takeshi²,Izumi Namiki³

Affiliation:

1. Department of Gastroenterology and Hepatology, Saitama Medical University

2. AbbVie GK Medical

3. Department of Gastroenterology, Musashino Red Cross Hospital

Publisher

Japan Society of Hepatology

Subject

Hepatology

Link

https://www.jstage.jst.go.jp/article/kanzo/62/11/62_690/_pdf

Reference22 articles.

1. 1) Messina JP, Humphreys I, Flaxman A, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 2015; 61: 77-87

2. 2) GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385: 117-171

3. 3) Gower E, Estes C, Blach S, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61: S45-S57

4. 4) Matsuo J, Mizui M, Okita H, et al. Follow up of the 987 blood donors found with hepatitis C virus infection over 9-18 years. Hepatol Res 2012; 42: 637-647

5. 5) Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol 2014; 61: S58-S68

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Post-marketing surveillance of ombitasvir/paritaprevir/ritonavir for patients with hepatitis C virus genotype 1b infection: A follow-up study of phase 2 and 3 clinical trials;Kanzo;2022-07-01